IRIS
VALENSISE, HERBERT CARMELO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 16.014
AS - Asia 3.722
EU - Europa 2.665
SA - Sud America 549
AF - Africa 58
OC - Oceania 16
Continente sconosciuto - Info sul continente non disponibili 4
AN - Antartide 1
Totale 23.029
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 15.900
SG - Singapore 2.129
IT - Italia 796
CN - Cina 640
BR - Brasile 435
RU - Federazione Russa 381
DE - Germania 290
VN - Vietnam 281
IE - Irlanda 229
HK - Hong Kong 208
FR - Francia 171
UA - Ucraina 150
GB - Regno Unito 140
FI - Finlandia 124
PL - Polonia 120
JP - Giappone 109
NL - Olanda 84
SE - Svezia 70
CA - Canada 63
IN - India 62
AR - Argentina 46
KR - Corea 38
BD - Bangladesh 37
ID - Indonesia 36
IQ - Iraq 31
MX - Messico 30
CZ - Repubblica Ceca 28
TR - Turchia 26
ES - Italia 24
ZA - Sudafrica 18
PS - Palestinian Territory 17
EC - Ecuador 16
AU - Australia 15
CO - Colombia 15
PK - Pakistan 15
AT - Austria 13
VE - Venezuela 12
NP - Nepal 11
BE - Belgio 10
CL - Cile 10
MA - Marocco 8
SA - Arabia Saudita 8
UZ - Uzbekistan 8
AE - Emirati Arabi Uniti 7
IL - Israele 7
EG - Egitto 6
IR - Iran 6
MY - Malesia 6
PY - Paraguay 6
AZ - Azerbaigian 5
DZ - Algeria 5
GT - Guatemala 5
KZ - Kazakistan 5
LT - Lituania 5
PH - Filippine 5
JO - Giordania 4
KE - Kenya 4
RO - Romania 4
TH - Thailandia 4
TN - Tunisia 4
BO - Bolivia 3
CH - Svizzera 3
DO - Repubblica Dominicana 3
ET - Etiopia 3
HN - Honduras 3
HU - Ungheria 3
LB - Libano 3
OM - Oman 3
PE - Perù 3
PT - Portogallo 3
RS - Serbia 3
TW - Taiwan 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AL - Albania 2
CG - Congo 2
CI - Costa d'Avorio 2
CR - Costa Rica 2
DK - Danimarca 2
GA - Gabon 2
GE - Georgia 2
GR - Grecia 2
JM - Giamaica 2
NG - Nigeria 2
SV - El Salvador 2
UY - Uruguay 2
AM - Armenia 1
AO - Angola 1
AQ - Antartide 1
BH - Bahrain 1
BY - Bielorussia 1
EU - Europa 1
GD - Grenada 1
GI - Gibilterra 1
GY - Guiana 1
HR - Croazia 1
KG - Kirghizistan 1
KH - Cambogia 1
LK - Sri Lanka 1
LV - Lettonia 1
MD - Moldavia 1
Totale 23.019
Salva come PNG Salva come JPEG
Città #
Wilmington 3.897
Houston 3.496
Woodbridge 3.392
Singapore 787
Fairfield 526
Ashburn 417
San Jose 399
Chandler 370
Ann Arbor 276
Dublin 229
Rome 215
Seattle 210
Beijing 209
Hong Kong 201
New York 166
Cambridge 165
Medford 151
Council Bluffs 145
Los Angeles 132
Jacksonville 113
Santa Clara 111
The Dalles 110
Ho Chi Minh City 105
Kraków 104
Zhengzhou 98
Tokyo 88
Helsinki 84
Dearborn 79
Boardman 75
Lawrence 69
Hanoi 62
Milan 59
Lauterbourg 56
Dallas 52
Buffalo 51
Moscow 48
São Paulo 48
North Bergen 46
Cedarhurst 38
San Diego 33
Redondo Beach 30
Chicago 28
Frankfurt am Main 26
London 26
Olomouc 25
Shanghai 23
Montreal 22
Orem 22
Amsterdam 21
Florence 21
Munich 21
Naples 21
Manchester 20
Phoenix 20
Chennai 19
Monte Vista 18
Mülheim 18
Turin 18
Brooklyn 16
Atlanta 15
Denver 15
Baghdad 14
Dhaka 14
Nanjing 14
Bologna 13
Boston 13
Guangzhou 13
Nuremberg 13
Poplar 13
San Francisco 13
Stockholm 13
Vancouver 13
Johannesburg 12
Palermo 12
Utrecht 12
Ankara 11
Rio de Janeiro 11
Warsaw 11
Brussels 10
Jakarta 10
Salt Lake City 10
Da Nang 9
Lappeenranta 9
Menlo Park 9
Mexico City 9
Norwalk 9
Seoul 9
Ascoli Piceno 8
Campinas 8
City of London 8
Curitiba 8
Hefei 8
Melbourne 8
Querétaro 8
Quito 8
Redwood City 8
Suzhou 8
Toronto 8
Brasília 7
Manaus 7
Totale 17.758
Salva come PNG Salva come JPEG
Nome #
Are Gestational and Essential Hypertension Similar? Left Ventricular Geometry and Diastolic Function 545
Medical treatment of early-onset mild gestational hypertension reduces total peripheral vascular resistance and influences maternal and fetal complications 523
Body composition during normal pregnancy: reference ranges 519
Abnormal maternal cardiac function precedes the clinical manifestation of fetal growth restriction 504
Fetal subcutaneous tissue thickness (SCTT) in healthy and gestational diabetic pregnancies 496
Normal fetal growth in women with antiphospholipid syndrome treated with high-dose intravenous immunoglobulin (IVIG) 480
Assessment of total vascular resistance and total body water in normotensive women during the first trimester of pregnancy. A key for the prevention of preeclampsia 477
Left ventricular midwall mechanics at 24 weeks' gestation in high-risk normotensive pregnant women: Relationship to placenta-related complications of pregnancy 469
Could birthweight prediction models be improved by adding fetal subcutaneous tissue thickness? 461
Molecular basis of thyrotropin and thyroid hormone action during implantation and early development 451
Multifrequency bioelectrical impedance analysis in women with a normal and hypertensive pregnancy 447
PP065. Assessment of total vascular resistance and total body water in normotensive women during the first trimester of pregnancy in order to predict hypertensive complications 437
Maternal and fetal hemodynamic effects induced by nitric oxide donors and plasma volume expansion in pregnancies with gestational hypertension complicated by intrauterine growth restriction with absent end-diastolic flow in the umbilical artery 432
Mild thyroid abnormalities and recurrent spontaneous abortion: diagnostic and therapeutical approach 431
Maternal total vascular resistance and concentric geometry: A key to identify uncomplicated gestational hypertension 429
The computerized fetal heart rate analysis in post-term pregnancy identifies patients at risk for fetal distress in labour 424
Diagnostic evaluation of women experiencing repeated in vitro fertilization failure. 417
Ultrasound-determined fetal subcutaneous tissue thickness for a birthweight prediction model 412
Molecular basis of thyrotropin and thyroid hormone action during implantation and early development 410
Increased expression of low-affinity insulin receptor isoform and insulin/insulin-like growth factor-I hybrid receptors in term placenta from insulin-resistant women with gestational hypertension 401
Pregnancy outcome in recurrent spontaneous abortion associated with antiphospholipid antibodies: a comparative study of intravenous immunoglobulin versus prednisone plus low-dose aspirin 399
Normal fetal growth in women with antiphospholipid syndrome treated with high dose intravenous immunoglobulins 394
Screening for pre-eclampsia in the first trimester: role of maternal hemodynamics and bioimpedance in non-obese patients 394
Nifedipine-induced changes in body composition in hypertensive patients at term 388
Schauta-Amreich Operation vs Piver II Procedure with Pelvic Lymphadenectomy for Cervical Cancer 387
The fetal body compartments and their detection during pregnancy. A review 379
GSTA1 gene variation associated with gestational hypertension and its involvement in pregnancy-related pathogenic conditions 372
Total body water estimation and maternal cardiac systolic function assessment in normal and gestational hypertensive pregnant women 358
Maternal body composition at term gestation and birth weight: is there a link? 357
Adjuvant vemurafenib in resected, BRAFV600mutation-positive melanoma (BRIM8): a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial 354
Maternal cardiac systolic function and total body water estimation in normal and gestational hypertensive women 350
Fetal monitoring indications for delivery and 2-year outcome in 310 infants with fetal growth restriction delivered before 32 weeks' gestation in the TRUFFLE study 290
Foetal heart rate deceleration with combined spinal-epidural analgesia during labour: A maternal haemodynamic cardiac study 271
The influence of doctor-patient and midwife-patient relationship in quality care perception of Italian pregnant women: An exploratory study 257
Maternal Hemodynamics from Preconception to Delivery: Research and Potential Diagnostic and Therapeutic Implications: Position Statement by Italian Association of Pre-Eclampsia and Italian Society of Perinatal Medicine 218
Assessment of venous hemodynamics and volume homeostasis during pregnancy: recommendations of the International Working Group on Maternal Hemodynamics 195
Correlation between maternal body composition and haemodynamic changes in pregnancy: different profiles for different hypertensive disorders 193
Fetal growth restriction and maternal cardiac function 187
Maternal hemodynamics early in labor: a possible link with obstetric risk? 185
Assessment of arterial function in pregnancy: recommendations of the International Working Group on Maternal Hemodynamics 183
Clinical opinion: the diagnosis and management of suspected fetal growth restriction: an evidence-based approach 182
Early and Late preeclampsia: Two different maternal hemodynamic states in the latent phase of the disease 181
The maternal cardiovascular effect of carbetocin compared to oxytocin in women undergoing caesarean section 180
Comparative analysis of 2-year outcomes in GRIT and TRUFFLE trials 179
A developmental approach to the prevention of hypertension and kidney disease: a report from the Low Birth Weight and Nephron Number Working Group 178
Antenatal Care of Preeclampsia: From the Inverted Pyramid to the Arrow Model? 174
Severe fetal growth restriction at 26–32 weeks: key messages from the TRUFFLE study 171
Research priorities for the future health of multiples and their families: The Global Twins and Multiples Priority Setting Partnership 167
Ultrasonographic evaluation of the second stage of labor. Predictive parameters for a successful vaginal delivery with or without neuraxial analgesia: a pilot study 167
Methods and considerations concerning cardiac output measurement in pregnant women: recommendations of the International Working Group on Maternal Hemodynamics 165
Is middle cerebral artery Doppler related to neonatal and 2-year infant outcome in early fetal growth restriction? 163
Hemodynamic guided treatment of hypertensive disorders in pregnancy: is it time to change our mind? 161
The Impact of Kidney Development on the Life Course: A Consensus Document for Action 160
Chronic pain management in pregnancy and lactation 156
Women with endometriosis at first pregnancy have an increased risk of adverse obstetric outcome 153
Restricted physical activity in pregnancy reduces maternal vascular resistance and improves fetal growth 152
Friendly help for clinical use of maternal hemodynamics 151
Hypertension in pregnancy and endothelial activation: An emerging risk factor for cardiovascular disease 150
Preterm delivery and elevated maternal total vascular resistance: signs of suboptimal cardiovascular adaptation to pregnancy? 149
Acetylsalicylic acid in pregnant women with chronic hypertension 146
Pregnancy complications in chronic hypertensive patients are linked to pre-pregnancy maternal cardiac function and structure 145
Persistent maternal cardiac dysfunction after preeclampsia identifies patients at risk for recurrent preeclampsia 144
Hemodynamic Prediction and Stratification of Hypertensive Disorders of Pregnancy: A Dream That Is Coming True? 143
Optimization of the viability of stem cells derived from umbilical cord blood after maternal supplementation with DHA during the second or third trimester of pregnancy: Study protocol for a randomized controlled trial 143
Outcome in early-onset fetal growth restriction is best combining computerized fetal heart rate analysis with ductus venosus Doppler: insights from the Trial of Umbilical and Fetal Flow in Europe 143
Functional hemodynamic testing in pregnancy: recommendations of the International Working Group on Maternal Hemodynamics 142
Preeclampsia: the role of persistent endothelial cells in uteroplacental arteries. Brosens I, Brosens JJ, Muter J, Puttemans P, Benagiano G. Am J Obstet Gynecol 2019;221:219-26 130
Effect of a nitric oxide donor on maternal hemodynamics in fetal growth restriction 130
Distinction between SGA and FGR by means of fetal umbilical vein flow and maternal hemodynamics 129
Treatment of pregnancies complicated by intrauterine growth restriction with nitric oxide donors increases placental expression of Epidermal Growth Factor-Like Domain 7 and improves fetal growth: A pilot study 121
Circulating EGFL7 distinguishes between IUGR and PE: an observational case–control study 121
Prenatal and postnatal imaging of multiple intracranial lipomas: Report of a Case 114
Fetal Umbilical Vein Flow in the Classification of Fetuses with Growth Restriction 109
The “Preeclampsia and Hypertension Target Treatment” (“PYTT”) study: a multicenter prospective study to evaluate the effectiveness of the antihypertensive therapy based on maternal hemodynamic findings 106
Cardiac Function 103
Systemic vascular resistance may influence the outcome of in vitro fertilization 100
Are Chlamydia Trachomatis and Neisseria Gonorrhoeae Screenings in Pregnant Women Being Properly Performed? A Single-Center Retrospective Observational Study in Italy 100
A practical approach to the management of thyroid dysfunction during pregnancy 99
Hemodynamic maladaptation and left ventricular dysfunction in chronic hypertensive patients at the beginning of gestation and pregnancy complications: a case control study 97
Maternal Cardiovascular Dysfunction is Associated with Hypoxic Cerebral and Umbilical Doppler Changes 90
D2. Screening of preeclampsia (PE) in the first trimester: high total vascular resistance (TVR) with a reduced fat mass increase the risk in normo BMI patients 89
Maternal cardiovascular profile is altered in the preclinical phase of normotensive early and late intrauterine growth restriction 85
Hemodynamic assessment in patients with preterm premature rupture of the membranes (pPROM) 85
The p63 C-terminus is essential for murine oocyte integrity 85
G2. Low pregestational fat mass and subsequent maternal cardiovascular maladaptation in early pregnancy. The missing link for preeclampsia 84
Definition, identification, implications and management of hypodynamic hypertension in pregnancy 82
F1. Is there a correlation between total body water distribution and haemodynamic changes during pregnancy? 80
Maternal peripheral vascular resistance at mid gestation in chronic hypertension as a predictor of fetal growth restriction 76
Are HLA-G polymorphisms associated to recurrent pregnancy loss? 75
Abnormal maternal cardiac function and morphology in pregnancies complicated by intrauterine fetal growth restriction 74
C-peptide and insulin levels at 24-30 weeks' gestation: An increased risk of adverse pregnancy outcomes? 71
G1. Maternal haemodynamics assessment in preterm delivery: two different haemodynamic profiles 71
Cell immunity and recurrent miscarriage 67
Restricted physical activity and maternal rest improve fetal growth: should we look for the reason in the cardiovascular modifications? 67
SARS-CoV-2, Endothelial Dysfunction, and the Renin-Angiotensin System (RAS): A Potentially Dangerous Triad for the Development of Pre-Eclampsia 66
Maternal hemodynamics for the identification of early fetal growth restriction in normotensive pregnancies 66
Maternal hemodynamics in early and late fetal growth restriction 65
Phenotypic characterization of the placenta from women with Multiple Sclerosis exposed to Natalizumab during pregnancy. 62
NO donors on top of anti-hypertensive therapy reduces complications in chronic hypertensive pregnancies with hypodynamic circulation 61
Prevention of recurrent miscarriage 60
Totale 22.441
Salva come PNG Salva come JPEG
Categoria #
all - tutte 64.170
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 64.170
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021102 0 0 0 0 0 0 0 0 0 0 78 24
2021/2022692 32 96 34 36 19 34 43 32 45 83 44 194
2022/20231.102 149 93 34 108 106 230 95 83 112 18 61 13
2023/2024434 52 8 11 10 27 115 26 13 10 18 11 133
2024/20253.348 37 407 225 104 63 392 310 153 356 183 621 497
2025/20264.661 359 186 565 599 533 232 567 664 535 418 3 0
Totale 23.424